Exchange transfusion in severe falciparum malaria. 1999

S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Malaria associated with complications or a fatal outcome is caused by Plasmodium falciparum. The mortality due to this disease is parallel to the degree of parasitemia. Successful use of exchange blood transfusion as a therapeutic adjunct for this infection was reported. The rationale for this form of therapy is based on (1) rapid reduction in parasite load by exchange transfusion, (2) removal of toxic substances and (3) reducing microcirculatory sludging. We describe here thirteen cases of severe falciparum malaria treated with infusion of quinine dihydrochloride and exchange transfusion 2,320-8,000 ml of whole blood. We observed that the greatest reduction in the average circulating infected red blood cells, from 20.7 per cent to 9.3 per cent, seemed to occur early in the first 2,000 ml of blood exchange and the parasitemia often reduced to 5.1 per cent in patients who had 4,000 ml of blood exchange. In order to reduce the initial parasitemia to 5 per cent by exchange transfusion, we suggest the volume of exchange transfusion should be 2,000 ml for average parasitemia 10 per cent, 4,000 ml for parasitemia > 20 per cent and 2,000-4,000 ml for parasitemia 10-20 per cent.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011803 Quinine An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. Biquinate,Legatrim,Myoquin,Quinamm,Quinbisan,Quinbisul,Quindan,Quinimax,Quinine Bisulfate,Quinine Hydrochloride,Quinine Lafran,Quinine Sulfate,Quinine Sulphate,Quinine-Odan,Quinoctal,Quinson,Quinsul,Strema,Surquina,Bisulfate, Quinine,Hydrochloride, Quinine,Sulfate, Quinine,Sulphate, Quinine
D005078 Exchange Transfusion, Whole Blood Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
February 2016, Journal of clinical and diagnostic research : JCDR,
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
January 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene,
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
January 1992, Infection,
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
April 2002, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
December 1989, The American journal of tropical medicine and hygiene,
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
May 1990, BMJ (Clinical research ed.),
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
April 1990, Lancet (London, England),
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
February 1990, Lancet (London, England),
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
September 1994, QJM : monthly journal of the Association of Physicians,
S Gulprasutdilog, and V Chongkolwatana, and P Buranakitjaroen, and N Jaroonvesama
October 1988, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!